| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Baicalein | Acute Liver Injury | 2 | PM | 34207230 | 📋 | Inhibition of Oxidative Stress and ALOX12 and NF-κB Pathways Contribute to the Protective Effect of Baicalein on Carbon Tetrachloride-Induced Acute Liver Injury |
| Baicalein | Acute Liver Injury | 1 | PM | 33272570 | 📋 | Baicalein attenuates acute liver injury by blocking NLRP3 inflammasome |
| Baicalein | Cholestasis | 1 | PM | 38442444 | 📋 | Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner |
| Baicalein | Hepatic Fibrosis | 1 | PM | 20079350 | 📋 | Antifibrotic Effects of Chronic Baicalein Administration in a CCl4 Liver Fibrosis Model in Rats |
| Baicalein | Hepatic Ischemia | 1 | PM | 27150843 | 📋 | Baicalein Pretreatment Reduces Liver Ischemia/Reperfusion Injury via Induction of Autophagy in Rats |
| Baicalein | Hepatic Ischemia-Reperfusion | 2 | PM | 38727775 | 📋 | Hepatoprotective effects of baicalein against liver ischemia-reperfusion injury and partial hepatectomy in a rat model |
| Baicalein | Hepatic Ischemia-Reperfusion | 1 | PM | 34650628 | 📋 | Baicalein pre-treatment alleviates hepatic ischemia/reperfusion injury in mice by regulating the Nrf2/ARE pathway |
| Baicalein | Hepatic Steatosis | 1 | PM | 35847050 | 📋 | Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation |
| Baicalein | Hepatopulmonary Syndrome | 1 | PM | 38779522 | 📋 | The Therapeutic Effects of Baicalein on the Hepatopulmonary Syndrome in the Rat Model of Chronic Common Bile Duct Ligation |
| Baicalein | Hepatotoxicity | 1 | PM | 33779329 | 📋 | The effect of baicalein on endoplasmic reticulum stress and autophagy on liver damage |
| Baicalein | Hepatotoxicity | 2 | PM | 32409930 | 📋 | A potent protective effect of baicalein on liver injury by regulating mitochondria-related apoptosis |
| Baicalein | Liver Cancer | 11 | PM | 38232757 | 📋 | Evidence and possible mechanism of Scutellaria baicalensis and its bioactive compounds for hepatocellular carcinoma treatment |
| Baicalein | Liver Cancer | 10 | PM | 38040128 | 📋 | Chemotherapeutic effect of baicalein/epirubicin combination against liver cell carcinoma in-vitro: Inducing apoptosis and autophagy |
| Baicalein | Liver Cancer | 9 | PM | 36070933 | 📋 | miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10 |
| Baicalein | Liver Cancer | 8 | PM | 34763315 | 📋 | Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m 6 A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway |
| Baicalein | Liver Cancer | 7 | PM | 33838155 | 📋 | MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling |
| Baicalein | Liver Cancer | 6 | PM | 33511213 | 📋 | Functional lncRNA-miRNA-mRNA Networks in Response to Baicalein Treatment in Hepatocellular Carcinoma |
| Baicalein | Liver Cancer | 3 | PM | 28747003 | 📋 | Baicalein: A Review of Its Anti-Cancer Effects and Mechanisms in Hepatocellular Carcinoma |
| Baicalein | Liver Cancer | 2 | PM | 26548344 | 📋 | Baicalein Inhibits Hepatocellular Carcinoma Cells Through Suppressing the Expression of CD24 |
| Baicalein | Liver Cancer | 1 | PM | 21803068 | 📋 | Baicalein Inhibits the Migration and Invasive Properties of Human Hepatoma Cells |
| Baicalein | Liver Cancer | 4 | PM | 11525598 | 📋 | Enchancing Effect of Patented Whey Protein Isolate (Immunocal) on Cytotoxicity of an Anticancer Drug |
| Baicalein | Liver Cancer | 5 | PM | 7954360 | 📋 | Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines |
| Baicalein | Liver Disease | 1 | PM | 32618193 | 📋 | Metabolic Interaction between Ammonia and Baicalein |
| Baicalein | MAFLD | 5 | PM | 36752061 | 📋 | Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction |
| Baicalein | MAFLD | 4 | PM | 35784718 | 📋 | Multi-Omics Reveals Inhibitory Effect of Baicalein on Non-Alcoholic Fatty Liver Disease in Mice |
| Baicalein | MAFLD | 2 | PM | 34406004 | 📋 | Baicalein Enhances the Effect of Acarbose on the Improvement of Nonalcoholic Fatty Liver Disease Associated with Prediabetes via the Inhibition of De Novo Lipogenesis |
| Baicalein | MAFLD | 1 | PM | 34107585 | 📋 | [Protective effect of baicalein on high fat-induced hepatocytes oxidative damage] |
| Baicalein | MAFLD | 3 | PM | 31909773 | 📋 | Baicalein reduces hepatic fat accumulation by activating AMPK in oleic acid-induced HepG2 cells and high-fat diet-induced non-insulin-resistant mice |
